denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Education Program
Session: Myelodysplastic Syndromes: What We Have and What We Want
Hematology Disease Topics & Pathways:
Biological, Diseases, bone marrow, CMML, Therapies, MDS, Myeloid Malignancies, Clinically relevant, transplantation, stem cells
Session: Myelodysplastic Syndromes: What We Have and What We Want
Hematology Disease Topics & Pathways:
Biological, Diseases, bone marrow, CMML, Therapies, MDS, Myeloid Malignancies, Clinically relevant, transplantation, stem cells
Saturday, December 5, 2020, 9:25 AM-9:30 AM
Disclosures: Scott: Jazz: Consultancy; Agios: Consultancy; Novartis: Research Funding; Incyte: Consultancy, Honoraria; Celgene: Consultancy, Honoraria, Research Funding.
See more of: Myelodysplastic Syndromes: What We Have and What We Want
See more of: Education Program
See more of: Education Program
<< Previous Presentation
|
Next Presentation